Shares of Inovio Pharmaceuticals Inc. INO slipped 2.91% to $4.01 Tuesday, on what proved to be an all-around favorable ...
Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...
Stocktwits on MSN12d
Inovio Pharma Stock Slips Ahead of Q3 Earnings: Retail’s BullishShares of Inovio Pharmaceuticals ($INO) slipped nearly 2% on Thursday afternoon ahead of the company’s third-quarter results, ...
Analyst Stephens covers INOVIO Pharmaceuticals highlighting its diverse clinical pipeline and FDA's consideration of INO-3107 Phase 1/2 trials for Accelerated Approval. Potential as the first non ...
Inovio Pharmaceuticals (NASDAQ:INO – Free Report) had its price objective cut by Royal Bank of Canada from $7.00 to $6.00 in ...
Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) had its target price reduced by HC Wainwright from $12.00 to $5.00 in a ...
H.C. Wainwright analyst Ram Selvaraju has reiterated their neutral stance on INO stock, giving a Hold rating on November 14.Don't Miss our ...
Inovio Pharmaceuticals (INO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Roy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback